New study eyes Tirzepatide's hidden impact on joints and heart
NCT ID NCT07567378
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This observational study in Mexico will follow 30 adults already taking tirzepatide for conditions like diabetes or obesity. Researchers will use MRI scans of the knees, CT scans of the heart, and body composition tests to see how the drug affects cartilage, heart fat, and overall health. The goal is to understand whether tirzepatide's benefits on joints occur independently of weight loss.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
tirzepatide
What this could lead to
If successful, this study could reveal how tirzepatide impacts joint health and heart fat, potentially guiding future treatments for arthritis and heart disease.
What could go wrong
This is a small, early observational study with only 30 participants, so results may not apply widely. It does not test tirzepatide directly, only observes people already taking it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
IMSS Clínica Río Magdalena
Mexico City, Mexico City, 01090, Mexico
Contact Phone: •••-•••-•••• Email: •••••@•••••